Cannabis Rescheduling
A Defining Moment for Nursing Leadership
In healthcare, policy does not lead practice—nursing does. Nurses are the first to hear patients’ questions, the first to witness relief or harm, and the first to navigate care when guidance is unclear. Long before legislation changes, nurses are already practicing at the edges of what policy has yet to acknowledge. Registered Nurses have been advocating for the safe use of cannabis for over 20 years and Cannabis Nursing is now a recognized specialty practice. As nurses, our role remains the same: protect patients, educate with integrity, and advocate for systems that support whole-person care.
December 18th will be remembered as a historic turning point in American healthcare. On that day, President Donald J. Trump formally initiated the process to remove cannabis from Schedule I of the Controlled Substances Act, while also calling on Congress to modernize federal policy around hemp-derived cannabinoid products, including full-spectrum CBD. For nurses who have spent years supporting patients in cannabinoid care—often without institutional recognition—this moment represents something rare in healthcare: policy beginning to catch up to nursing practice.
This is not a moment for hype or celebration. It is a moment for leadership, clarity, and responsibility.
Why Rescheduling Matters—Especially to Nurses - For more than 50 years, cannabis has been classified as a Schedule I substance, reserved for drugs deemed to have no accepted medical use and a high potential for abuse. This classification restricted research, stalled education, and left healthcare professionals—particularly nurses—without formal guidance, despite widespread patient use. Yet patients never stopped asking. And nurses never stopped listening.
Across oncology, palliative care, chronic pain, mental health, and aging populations, nurses have supported patients using cannabinoids for symptom relief and quality-of-life support. Often, this care occurred quietly—under stigma, regulatory ambiguity, and professional risk. Schedule I policy created a deep disconnect between clinical reality and federal law.
The move toward Schedule III acknowledges what nurses, patients, and researchers have long known:
Cannabis has accepted medical use
It carries lower abuse potential than Schedule I substances
It warrants a science-based, healthcare-centered regulatory framework
Rescheduling does not make cannabis benign, nor does it simplify dosing, interactions, or patient variability. But it does allow clinicians—especially nurses—to engage openly, ethically, and transparently instead of practicing in the shadows.
Earlier this year, I analyzed Schedule VI, a public-health-focused classification proposed by Americans for Safe Access, which I continue to believe better reflects whole-plant medicine and nursing practice. Still, Schedule III represents meaningful forward movement—and movement matters. You can read the blog on why Schedule VI is more suitable for patients and health professionals here.
What Schedule III Changes—and What It Doesn’t - From a nursing perspective, precision matters. What Schedule III does:
Expands access to clinical and real-world research
Reduces barriers for academic and pharmaceutical study
Encourages standardized safety, labeling, and quality controls
Normalizes patient–provider conversations
What it does not do:
Federally legalize cannabis
Override state cannabis laws
Resolve criminal justice or equity concerns
Automatically integrate cannabis into every healthcare setting
This represents a practical and necessary shift, rather than an ultimate finish line. It marks the beginning of a broader, ongoing effort to drive meaningful change. In parallel, federal agencies have been directed to take specific actions aimed at ensuring these initiatives are implemented effectively and sustainably over time. Including:
Expanding medical cannabis and CBD research
Clarifying hemp-derived cannabinoid regulations
Establishing safety standards, labeling guidance, and THC limits
For nurses, this signals a long-overdue transition away from restrictive, prohibition-driven policies toward a more modern, patient-centered approach to oversight. This change empowers healthcare professionals to focus more on individual patient needs and evidence-based care rather than navigating outdated regulations.
Reintroducing Nuance into Cannabis Care - Nurses are trained to navigate complexity and make informed decisions in diverse situations. We understand that most therapies involve a careful balance of benefits and risks, providing relief while requiring responsibility and thoughtful management. Cannabis is no different—it offers potential therapeutic benefits but also calls for education, monitoring, and individualized care to ensure its safe and effective use. As healthcare professionals, we are here to guide patients through this balance with knowledge and compassion.
It is neither a miracle cure nor a public health menace. Instead, it is a therapeutic tool—one that demands education, careful assessment, dosing expertise, and ethical boundaries. Rescheduling it opens the door for healthcare professionals to engage thoughtfully and responsibly, rather than defensively.
For patients, it brings validation and legitimacy. For clinicians, it fosters meaningful, informed dialogue. And for nurses, it reinforces what we’ve always practiced: compassionate, evidence-based care.
The Impact on Nurses: From Informal Guides to Recognized Leaders - Nurses remain the most trusted profession in America, yet many have supported cannabinoid care without institutional recognition. That landscape is changing.
In 2023, the American Nurses Association formally adopted the Scope & Standards of Cannabis Nursing, establishing cannabis nursing as a recognized specialty practice, with certification pathways emerging and board certification on the horizon. This matters. It validates years of nurse-led advocacy, education, and ethical care delivery—often done without protection, reimbursement, or formal acknowledgment.
At Holistic Caring & The Green Nurse, our leadership team has spent more than a decade:
Coaching patients to use cannabinoids safely and effectively
Educating nurses in cannabinoid science and holistic assessment
Building curriculum to prepare nurses for specialty practice
As a California Board of Registered Nursing provider since 2019—and with our entire ecosystem online since 2020—we have seen what happens when nurses are empowered with education instead of constrained by outdated policy.
Today, nurses in our Cannabis Nurse Health Coach Certificate Program can:
Learn on demand through mobile education
Participate in monthly mastermind sessions
Access compliant business-building tools to launch ethical practices
The recent decision to reschedule cannabis affirms what nurses have long known and advocated for: nursing belongs at the very center of cannabinoid care, not relegated to its margins. For years, nurses have been at the forefront, guiding patients through the complexities of cannabinoid medicine, and this policy change finally acknowledges their crucial role in providing safe and effective care.
The Impact on Patients: Normalization Without Minimization - For patients, it appears that access to state-licensed medical cannabis dispensaries will remain unchanged, so people may continue to purchase products from their local medical or adult use dispensary as usual. What shifts under Schedule III is what becomes possible within traditional healthcare systems. This change could pave the way for FDA-approved cannabis medications to be prescribed by doctors and potentially covered by health insurance, integrating cannabis into mainstream medicine. Looking ahead, we anticipate:
Prescription cannabinoid formulations
Pharmacy-based distribution models
Expanded clinician education on the endocannabinoid system
Eventual payer and insurer participation
As stigma fades, conversations expand. This opens pathways that may reduce over-reliance on pharmaceuticals—particularly in chronic pain, inflammatory conditions, and symptom clusters where quality of life matters most.
This is not about replacing medicine; it’s about responsibly expanding the range of options available for treatment. It recognizes the importance of integrating new and traditional approaches to healthcare in a balanced way. Additionally, this doesn’t mean that the botanical pathway to cannabis medicine will disappear. Instead, it ensures that patients continue to have access to the natural forms of cannabis while also exploring innovative methods to enhance care and outcomes within the conventional care system.
A Global Signal - Interestingly, this shift is being watched globally. Canada’s cannabis industry, already operating in a federally legal framework, sees U.S. rescheduling as a signal that international alignment on research and standards may finally be possible. After all, healthcare doesn’t stop at borders—evidence travels, and nursing practice evolves alongside it.
Research, Regulation, and Nursing Responsibility - To navigate this evolving landscape, federal agencies like the Department of Health and Human Services (HHS), the Food and Drug Administration (FDA), the Centers for Medicare & Medicaid Services (CMS), and the National Institutes of Health (NIH) have been tasked with broadening the scope of cannabis research. This new directive emphasizes the need to incorporate real-world evidence into studies and pay special attention to vulnerable groups, including young people and older adults, who may be disproportionately affected.
Despite these positive steps, nurses must remain vigilant and informed. The potency of available cannabis products is on the rise, which brings with it tangible neuropsychiatric and dependency risks that cannot be overlooked. It is crucial that the integration of cannabis into mainstream healthcare is guided by robust education and solid scientific evidence, rather than being driven by commercial interests.
Ultimately, the role of nursing leadership will be pivotal in this transition. Their guidance and advocacy will determine whether this new chapter prioritizes public health and patient safety or if it simply repeats the public health mistakes of the past.
The Bottom Line for Nurses - For nurses, cannabis rescheduling is not a political win—it is a professional inflection point. It affirms that the education, advocacy, and ethical care nurses have provided for decades now belong within legitimate healthcare systems. It also raises the bar. Nurses must lead with evidence, practice with discernment, and speak clearly about both benefits and risks. This is our moment to shape standards, influence education, and protect patients from the harms that arise when therapies outpace oversight. Nursing leadership will determine whether cannabinoid care becomes another fragmented experiment—or a model of responsible, whole-person medicine.
Our Commitment Moving Forward - We’re here to help you navigate this new era with clarity and compassion.
At Holistic Caring & The Green Nurse, we will continue to:
Evidence-based education for patients and professionals
Produce trusted clinical content via our Green Nurse Podcast and Clinical Conversations Webcasts
At Bloom Hemp CBD, we remain committed to:
USDA Organic, full-spectrum hemp CBD
Symptom-targeted formulations
Shipping to all 50 states
Free nurse support and email care plans with every order
Visit our Services tab, complete a short intake form, and receive personalized product guidance, lifestyle tips, and free educational resources—helping you heal without the high.
📞 Call our free nurse line: 970-404-4673 (HOPE) for any questions
After 37 years as a nurse, I’ve come to understand that meaningful change in healthcare rarely happens overnight. It’s a gradual journey that begins with the lived experiences of patients, shapes clinical practice, and eventually influences policy. Each step requires time, effort, and persistence, but it’s these steady, incremental shifts that lay the foundation for lasting progress.
Official resources:
Thank You Sherri! This says it all 👍🏾👏🏾🤎
Phenomenal look at how policy follows practice instead of leading it. The framing of nurses as advocates who've been working in regulatory gray zones for decades really clarifies how significant Schedule III is. I remember a palliative care nurse friend talking in 2016 about how patients would ask about cannabis and she couldn't give guidance even tho it helped symptoms. Now that cannabis nursing is recognized as a specialty, it legitimizes what nurses have been doing without formal backing.